140 related articles for article (PubMed ID: 33486102)
21. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.
Belderbos J; Heemsbergen W; Hoogeman M; Pengel K; Rossi M; Lebesque J
Radiother Oncol; 2005 May; 75(2):157-64. PubMed ID: 15890421
[TBL] [Abstract][Full Text] [Related]
22. Women at increased risk for cardiac toxicity following chemoradiation therapy for esophageal carcinoma.
Tait LM; Meyer JE; McSpadden E; Cheng JD; Baciewicz FA; Meropol NJ; Cohen SJ; Wozniak AJ; Choi M; Konski AA
Pract Radiat Oncol; 2013; 3(4):e149-55. PubMed ID: 24674412
[TBL] [Abstract][Full Text] [Related]
23. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
Xiao L; Liu N; Zhang G; Zhang H; Gao S; Fu Z; Wang S; Yu Q; Yu J; Yuan S
PLoS One; 2017; 12(1):e0170901. PubMed ID: 28125698
[TBL] [Abstract][Full Text] [Related]
24. Preoperative contralateral lung radiation dose is associated with postoperative pulmonary toxicity in patients with locally advanced non-small cell lung cancer treated with trimodality therapy.
Guo W; Hui X; Alfaifi S; Anderson L; Robertson S; Hales R; Hu C; McNutt T; Broderick S; Naidoo J; Battafarano R; Yang S; Voong KR
Pract Radiat Oncol; 2018; 8(4):e239-e248. PubMed ID: 29960625
[TBL] [Abstract][Full Text] [Related]
25. Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer.
Shaikh T; Churilla TM; Monpara P; Scott WJ; Cohen SJ; Meyer JE
Pract Radiat Oncol; 2016; 6(6):388-394. PubMed ID: 27025161
[TBL] [Abstract][Full Text] [Related]
26. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
[TBL] [Abstract][Full Text] [Related]
27. Clinical Application of a Hybrid RapidArc Radiotherapy Technique for Locally Advanced Lung Cancer.
Silva SR; Surucu M; Steber J; Harkenrider MM; Choi M
Technol Cancer Res Treat; 2017 Apr; 16(2):224-230. PubMed ID: 27680023
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric and clinical predictors for radiation-induced esophageal injury.
Ahn SJ; Kahn D; Zhou S; Yu X; Hollis D; Shafman TD; Marks LB
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):335-47. PubMed ID: 15667951
[TBL] [Abstract][Full Text] [Related]
29. The prognostic value of irradiated lung volumes on the prediction of intra-/ post-operative mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer. A retrospective multicenter study.
Kup PG; Nieder C; Geinitz H; Henkenberens C; Besserer A; Oechsner M; Schill S; Mücke R; Scherer V; Combs SE; Adamietz IA; Fakhrian K
J Cancer; 2015; 6(3):254-60. PubMed ID: 25663943
[TBL] [Abstract][Full Text] [Related]
30. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
[TBL] [Abstract][Full Text] [Related]
31. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
[TBL] [Abstract][Full Text] [Related]
32. Dosimetric definitions of total lung volumes in calculating parameters predictive for radiation-induced pneumonitis.
Kabolizadeh P; Kalash R; Huq MS; Greenberger JS; Heron DE; Beriwal S
Am J Clin Oncol; 2015 Aug; 38(4):401-4. PubMed ID: 24064747
[TBL] [Abstract][Full Text] [Related]
33. Predictive factors for acute esophageal toxicity in thoracic radiotherapy.
Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
Tohoku J Exp Med; 2006 Apr; 208(4):299-306. PubMed ID: 16565592
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.
Shiraishi Y; Xu C; Yang J; Komaki R; Lin SH
Radiother Oncol; 2017 Oct; 125(1):48-54. PubMed ID: 28917586
[TBL] [Abstract][Full Text] [Related]
35. Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis.
Makishima H; Ishikawa H; Terunuma T; Hashimoto T; Yamanashi K; Sekiguchi T; Mizumoto M; Okumura T; Sakae T; Sakurai H
J Radiat Res; 2015 May; 56(3):568-76. PubMed ID: 25755255
[TBL] [Abstract][Full Text] [Related]
36. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
[TBL] [Abstract][Full Text] [Related]
37. Esophageal wall dose-surface maps do not improve the predictive performance of a multivariable NTCP model for acute esophageal toxicity in advanced stage NSCLC patients treated with intensity-modulated (chemo-)radiotherapy.
Dankers F; Wijsman R; Troost EG; Monshouwer R; Bussink J; Hoffmann AL
Phys Med Biol; 2017 May; 62(9):3668-3681. PubMed ID: 28379845
[TBL] [Abstract][Full Text] [Related]
38. Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patients.
Modesto A; Dalmasso C; Lusque A; Vieillevigne L; Izar F; Moyal E; Carrère N; Guimbaud R; Rives M
Cancer Radiother; 2020 Apr; 24(2):88-92. PubMed ID: 32156457
[TBL] [Abstract][Full Text] [Related]
39. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.
Lertbutsayanukul C; Tharavej C; Klaikeaw N; Prayongrat A; Lowanitchai C; Sriuranpong V
Thorac Cancer; 2017 May; 8(3):219-228. PubMed ID: 28322515
[TBL] [Abstract][Full Text] [Related]
40. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]